SGMT · Sagimet Biosciences Inc. · Documents
Market Cap
$676.29M
Shares
62.16M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-13 | — | |
| 8-K | 2026-08-11 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| Investor Event Transcript | 2026-08-11 | 2026-09-30 | |
| 8-K | 2026-07-21 | 2026-07-20 | |
| 8-K | 2026-06-12 | — | |
| 8-K | 2026-06-03 | 2026-05-28 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| 8-K | 2026-04-28 | 2026-04-27 | |
| 8-K | 2026-04-27 | — | |
| 8-K | 2026-04-27 | — | |
| DEF 14A | 2026-04-21 | 2026-06-12 | |
| 8-K | 2026-04-21 | 2026-04-20 | |
| 10-K | 2026-03-11 | 2025-12-31 | |
| 8-K | 2026-03-11 | — | |
| 8-K | 2026-02-02 | — | |
| 8-K | 2025-12-18 | — | |
| 8-K | 2025-12-17 | — | |
| 10-Q | 2025-11-13 | 2025-09-30 | |
| 8-K | 2025-11-13 | — | |
| 8-K | 2025-10-23 | — | |
| 8-K | 2025-08-22 | 2025-08-18 | |
| 8-K | 2025-08-14 | — | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-08-13 | — | |
| 8-K | 2025-06-10 | 2025-06-06 | |
| 8-K | 2025-06-04 | — | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-04-30 | 2025-04-29 | |
| DEF 14A | 2025-04-30 | 2025-06-09 | |
| 10-K | 2025-03-12 | 2024-12-31 | |
| 8-K | 2025-03-12 | — | |
| 8-K | 2025-03-11 | — | |
| 8-K | 2025-02-14 | — | |
| 8-K | 2025-01-02 | — | |
| 8-K | 2024-11-14 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-08-16 | 2024-08-15 | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-14 | — | |
| 8-K | 2024-08-01 | 2024-07-30 | |
| 8-K | 2024-07-02 | — | |
| 8-K/A | 2024-06-13 | 2024-06-05 | |
| 8-K | 2024-06-06 | 2024-06-05 | |
| 8-K | 2024-05-23 | — | |
| 8-K | 2024-05-15 | — | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 8-K | 2024-05-06 | 2024-05-03 |
Showing 1–50 of 68 filings
Key facts
CIK
1400118
CUSIP
786700104
13F (30d)
74 filings
74 filers
Visit website
Investor relations